In this study, a calcineurin inhibitor-free regimen using sirolimus-MMF was as effective as a cyclosporine-based regimen in terms of survival, rejection, and renal function. American Journal of Transplantation
This is the first multicenter, prospective, randomized trial to compare alemtuzumab induction plus tacrolimus monotherapy with conventional therapy in low-risk kidney transplant recipients.
Findings suggest that renal function assessment in young and healthy males may provide incremental information on cardiovascular risk than a single measure of traditional risk factors. European Heart Journal
Coronary artery calcification is prevalent in patients with chronic kidney disease. Yet, data on the reliability and validity of high-resolution computerized tomography in patients with CKD is lacking. Nephrology Dialysis Transplantation
